MDT Logo

Medtronic plc (MDT) 

NYSE
Market Cap
$110.56B
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
367 of 774
Rank in Industry
48 of 99

Largest Insider Buys in Sector

MDT Stock Price History Chart

MDT Stock Performance

About Medtronic plc

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and …

Insider Activity of Medtronic plc

Over the last 12 months, insiders at Medtronic plc have bought $0 and sold $4.7M worth of Medtronic plc stock.

On average, over the past 5 years, insiders at Medtronic plc have bought $2.32M and sold $15.44M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 5,010 shares for transaction amount of $517,333 was made by ANDERSON RICHARD H (director) on 2021‑12‑16.

List of Insider Buy and Sell Transactions, Medtronic plc

2024-06-07SaleChairman and CEO
19,113
0.0015%
$83.77$1.6M+4.84%
2024-04-08SaleEVP & President, Surgical OU
854
<0.0001%
$83.14$71,002+1.36%
2024-02-21SaleEVP & President Cardiovascular
30,695
0.0023%
$85.13$2.61M-2.08%
2023-12-19SaleEVP & Pres Neuroscience
4,997
0.0004%
$82.17$410,603+3.27%
2023-08-23SaleEVP Global Ops & Supply Chain
10,000
0.0008%
$83.84$838,400-2.28%
2023-08-14SaleEVP & Pres Neuroscience
1,000
<0.0001%
$83.38$83,380-1.82%
2023-08-04SaleEVP & President, Surgical OU
1,352
0.0001%
$84.11$113,717-2.64%
2023-07-14SaleEVP & Pres Neuroscience
2,000
0.0002%
$87.97$175,940-6.21%
2023-07-10SaleEVP and Pres. Global Regions
5,514
0.0004%
$86.58$477,420-4.88%
2022-12-13SaleEVP & President Cardiovascular
16,631
0.0013%
$80.50$1.34M+3.72%
2022-10-14SaleEVP and Pres. Global Regions
2,404
0.0002%
$81.54$196,015+2.51%
2022-03-18SaleEVP & Chief Financial Officer
682
<0.0001%
$110.00$75,020-19.30%
2022-03-11SaleSVP, Chief HR Officer
6,000
0.0005%
$105.30$631,800-14.10%
2021-12-23SaleEVP & Pres. Medical Surgical
7,218
0.0005%
$102.04$736,525-8.14%
2021-12-16Purchasedirector
5,010
0.0004%
$103.26$517,333-6.07%
2021-12-06SaleEVP & Chief Financial Officer
682
<0.0001%
$110.00$75,020-11.83%
2021-09-30SaleSVP General Counsel & Corp Sec
49,147
0.0037%
$126.58$6.22M-16.50%
2021-08-31SaleSVP General Counsel & Corp Sec
50,775
0.0038%
$134.17$6.81M-20.23%
2021-08-25SaleCEO
10,100
0.0007%
$132.67$1.34M-20.38%
2021-08-25SaleEVP & Pres Diabetes/Cardiovasc
28,419
0.0021%
$134.08$3.81M-20.38%

Insider Historical Profitability

4.91%
ISHRAK OMARExecutive Chairman
561032
0.0437%
$86.2127+5.04%
ANDERSON RICHARD Hdirector
108374
0.0085%
$86.2160+0.88%
POZEN ROBERT Cdirector
60964
0.0048%
$86.2111+11.75%
Lenehan James Tdirector
47028
0.0037%
$86.2111+7.69%
PARKHILL KAREN LEVP & Chief Financial Officer
34946
0.0027%
$86.2116+19.19%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$11.01B9.85126.28M-0.21%-$23.07M0.2
BlackRock$9.93B8.89113.98M-3.87%-$400.24M0.22
State Street$5.28B4.6860.07M-1.39%-$74.31M0.22
JPMorgan Chase$2.76B2.4731.63M+24.59%+$543.97M0.25
Capital Research Global Investors$2.69B2.4130.88M+7.09%+$178.14M0.61
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.